Compare SOPH & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOPH | AIRS |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 374.1M | 328.7M |
| IPO Year | 2021 | 2021 |
| Metric | SOPH | AIRS |
|---|---|---|
| Price | $4.98 | $5.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | 88.5K | ★ 1.1M |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $151,818,000.00 |
| Revenue This Year | $23.09 | $5.19 |
| Revenue Next Year | $19.57 | $5.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.59 | $1.51 |
| 52 Week High | $5.70 | $12.00 |
| Indicator | SOPH | AIRS |
|---|---|---|
| Relative Strength Index (RSI) | 51.48 | 61.36 |
| Support Level | $4.54 | $2.40 |
| Resistance Level | $5.29 | $6.90 |
| Average True Range (ATR) | 0.28 | 0.39 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 71.64 | 55.38 |
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.